Previous 10 | Next 10 |
Summary Invitae Corporation has one chance to leverage itself into profitability in the next 12 - 18 months. The cash balance is barely enough to cover the company's cash burn, even if it achieves its 2023, leaving little room for error. Executing the "realignment plan" must b...
Some stocks have tumbled so much this year it's easy to imagine spectacular recovery stories. I'm talking about the idea of becoming a multibagger for investors ready to bet on better days ahead. Two stocks that could climb fivefold if they make progress toward their goals are Teladoc Hea...
Summary CareDx reported lackluster performance in the third quarter, with core testing revenue down by 2.5%, mirroring intensifying competitive dynamics impacting its pricing power. Competitive dynamics are exacerbated by the company's expansion in niche markets with structurally ...
On a day when US stock markets are seeing outsized gains, upside for Invitae ( NYSE: NVTA ) and Pacific Biosciences of California ( NASDAQ: PACB ) is among the highest in the biomedical space as they are up, respectively, 39% and 21% in Thursday afternoon trading. ...
October CPI Data Is Out & These Penny Stocks Are Ripping Higher If you’re looking for penny stocks to buy, the trend is your friend, as they say. Now that October’s CPI inflation data is out, the market has reacted, and the bulls are trying to take control. General...
Invitae Showcases Advances in Medical Genomics at the National Society of Genetic Counselors (NSGC) 41st Annual Conference PR Newswire - Heart of Genetic Counseling Award recognizing excellence in patient care will be presented by Invitae and NSGC - SAN FRANCISCO...
Invitae (NYSE: NVTA) stock was absolutely crushing it on Wednesday, with its shares skyrocketing 19.4% higher as of 11:11 a.m. ET. The huge gain came after the medical genetics company announced its third-quarter results following the market close on Tuesday. The company reporte...
The following slide deck was published by Invitae Corporation in conjunction with their 2022 Q3 earnings call. For further details see: Invitae Corporation 2022 Q3 - Results - Earnings Call Presentation
Invitae Corporation (NVTA) Q3 2022 Earnings Conference Call November 8, 2022 16:30 ET Company Participants Hoki Luk - Investor Relations Ken Knight - President and Chief Executive Officer Roxi Wen - Chief Financial Officer Conference Call Participants ...
Invitae press release ( NYSE: NVTA ): Q3 GAAP EPS of -$1.27 misses by $0.43 . Revenue of $133.54M (+16.7% Y/Y) beats by $2.16M . GAAP gross margin was 12.4%. Non-GAAP gross margin was 45.9% as compared with 40.1% in the second quarter of 2022 and 35.6% in the t...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...